Regulatory challenges and Quality of ATMPs - a European regulator's perspective

被引：0

作者：

Rees, Ian ^{[1
]}

Glassford, Janet ^{[1
]}

机构：

[1] MHRA, London, England

来源：

HUMAN GENE THERAPY | 2018年 / 29卷 / 07期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

INV06

引用

页码：A4 / A4

页数：1

共 50 条

[11] Rosiglitazone: a European regulatory perspective
Blind, E.
Dunder, K.
de Graeff, P. A.
Abadie, E.
DIABETOLOGIA, 2011, 54 (02) : 213 - 218
[12] Rosiglitazone: a European regulatory perspective
E. Blind
K. Dunder
P. A. de Graeff
E. Abadie
Diabetologia, 2011, 54 : 213 - 218
[13] Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective
Salmikangas, Paula
Schuessler-Lenz, Martina
Ruiz, Sol
Celis, Patrick
Reischl, Ilona
Menezes-Ferreira, Margarida
Flory, Egbert
Renner, Matthias
Ferry, Nicolas
REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 103 - 130
[14] A regulator's perspective
Wissman, K
2001 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-3, 2001, : 56 - 57
[15] RISK MEASURES DERIVED FROM A REGULATOR'S PERSPECTIVE ON THE REGULATORY CAPITAL REQUIREMENTS FOR INSURERS
Cai, Jun
Mao, Tiantian
ASTIN BULLETIN, 2020, 50 (03): : 1065 - 1092
[16] Regulatory challenges - My personal perspective
Martinez, M.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2023, 46 : 5 - 6
[17] Regulatory competition or harmonization of laws? Guidelines for the European regulator
Van den Bergh, R
ECONOMICS OF HARMONIZING EUROPEAN LAW, 2002, : 27 - 49
[18] Risk ManagementA European Regulatory Perspective
Jane N. S. Moseley
Drug Safety, 2004, 27 : 499 - 508
[19] Risk management - A European regulatory perspective
Moseley, JNS
DRUG SAFETY, 2004, 27 (08) : 499 - 508
[20] REGULATORY REFORM AND LIBERALIZATION - A EUROPEAN PERSPECTIVE
ENCAOUA, D
INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION, 1991, 9 (01) : 1 - 7

← 1 2 3 4 5 →